Kowalski Christoph, Post Stefan, Seufferlein Thomas, Benz Stefan R, Ferencz Julia, Wesselmann Simone
1 Department for Certification, German Cancer Society, Berlin, Germany.
2 University Medical Center, Mannheim, Germany.
Cancer Control. 2018 Jan-Mar;25(1):1073274818765475. doi: 10.1177/1073274818765475.
Improvements in health care depend on research involving health-care providers (HCPs) and health-care organizations (HCOs). Existing research suggests that involvement in research studies is still much lower than it could be. This study investigates factors that may impede or facilitate research involvement. A standardized online questionnaire was used to carry out a survey, in 3 countries, of key informants in colorectal cancer centers that hold certification in accordance with the requirements of the German Cancer Society. A total of 184 individuals responded (response rate 65%). The respondents found it difficult to identify studies suitable for their patients (40% agreement), criticized the small overall number of studies available (48%), and found that many studies are not worthwhile financially (56%). Among respondents who were not involved in studies as the principal investigators (PIs), 66% agreed they lacked the research infrastructure needed and 81% that they did not have enough staff. Among respondents who were involved as PIs, only 22% indicated that their hospital management encouraged them to initiate and conduct clinical trials. Eighty-five percent of the respondents agreed that the general population lacks information about the importance of studies. Five recommendations for health policy makers are derived from these findings for ways of increasing the involvement of HCPs and HCOs in research, and in cancer research in particular.
医疗保健的改善依赖于涉及医疗保健提供者(HCPs)和医疗保健组织(HCOs)的研究。现有研究表明,参与研究的程度仍远低于应有的水平。本研究调查了可能阻碍或促进研究参与的因素。在3个国家,使用标准化在线问卷对符合德国癌症协会要求并获得认证的结直肠癌中心的关键信息提供者进行了调查。共有184人回复(回复率65%)。受访者发现很难为其患者确定合适的研究(40%表示认同),批评现有研究总数较少(48%),并发现许多研究在经济上不值得(56%)。在未作为主要研究者(PIs)参与研究的受访者中,66%同意他们缺乏所需的研究基础设施,81%表示他们没有足够的工作人员。在作为PIs参与研究的受访者中,只有22%表示他们的医院管理层鼓励他们发起和开展临床试验。85%的受访者同意普通民众缺乏关于研究重要性的信息。根据这些发现,为提高HCPs和HCOs参与研究,特别是癌症研究的程度,向卫生政策制定者提出了五项建议。